During the past decade, Centro Modelo de Cardiologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Modelo de Cardiologia" #1 collaborator was "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Centro Modelo de Cardiologia" are "Asthma" (2 trials), "Cardiovascular Disease" (2 trials), "Coronary Artery Disease" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Centro Modelo de Cardiologia" in a lesser frequency.

Most popular intervention types in "Centro Modelo de Cardiologia" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "bococizumab (PF-04950615)" (2 trials), "Apabetalone" (1 trials), "Atorvastatin" (1 trials) and "Lebrikizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Modelo de Cardiologia" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Centro Modelo de Cardiologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centro Modelo de Cardiologia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Modelo de Cardiologia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".